T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
LSB Industries
LXU
$711M
| $384K | ﹤0.01% |
47,758
+8,978
| +23% | +$71.3K |
|
2352
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $384K | ﹤0.01% |
3,400
| – | – |
|
2353
LSI Industries
LYTS
$912M
| $383K | ﹤0.01% |
23,705
+213
| +0.9% | +$3.26K |
|
2354
LegalZoom.com
LZ
$993M
| $383K | ﹤0.01% |
60,195
+1,651
| +3% | +$10.8K |
|
|
ACR
2355
ACRES Commercial Realty
ACR
$101M
| $382K | ﹤0.01% |
24,390
| – | – |
|
|
CVGW
2356
DELISTED
Calavo Growers
CVGW
| $382K | ﹤0.01% |
13,355
+401
| +3% | +$9.79K |
|
2357
Vanguard Dividend Appreciation ETF
VIG
$115B
| $382K | ﹤0.01% |
1,928
| – | – |
|
2358
NN Inc
NNBR
$298M
| $381K | ﹤0.01% |
97,639
| – | – |
|
2359
Phathom Pharmaceuticals
PHAT
$743M
| $381K | ﹤0.01% |
21,049
+474
| +2% | +$6.63K |
|
2360
SSR Mining
SSRM
$6.49B
| $381K | ﹤0.01% |
66,904
+2,324
| +4% | +$12.2K |
|
|
CDMO
2361
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $380K | ﹤0.01% |
33,326
+294
| +0.9% | +$2.95K |
|
2362
Tejon Ranch
TRC
$443M
| $379K | ﹤0.01% |
21,568
+136
| +0.6% | +$2.42K |
|
2363
Yext
YEXT
$613M
| $377K | ﹤0.01% |
54,339
+2,166
| +4% | +$12K |
|
|
IRBT
2364
DELISTED
iRobot
IRBT
| $376K | ﹤0.01% |
43,159
-568
| -1% | -$4.92K |
|
2365
Nu Skin
NUS
$236M
| $376K | ﹤0.01% |
51,009
+4,400
| +9% | +$41.1K |
|
2366
Olema Pharmaceuticals
OLMA
$920M
| $376K | ﹤0.01% |
31,458
+216
| +0.7% | +$2.76K |
|
2367
Genesco
GCO
$394M
| $374K | ﹤0.01% |
13,742
+348
| +3% | +$9.66K |
|
2368
Diebold Nixdorf
DBD
$2.45B
| $373K | ﹤0.01% |
+8,335
| New | +$345K |
|
2369
FRP Holdings
FRPH
$425M
| $372K | ﹤0.01% |
12,427
+113
| +0.9% | +$3.3K |
|
2370
Weis Markets
WMK
$1.77B
| $371K | ﹤0.01% |
5,380
+197
| +4% | +$13.4K |
|
2371
Quanterix
QTRX
$135M
| $370K | ﹤0.01% |
28,493
-15,650
| -35% | -$209K |
|
2372
TFS Financial
TFSL
$4.93B
| $370K | ﹤0.01% |
28,751
-50
| -0.2% | -$659 |
|
|
KLG
2373
DELISTED
WK Kellogg Co
KLG
| $369K | ﹤0.01% |
21,529
+660
| +3% | +$11.3K |
|
2374
Washington Trust Bancorp
WASH
$767M
| $368K | ﹤0.01% |
11,408
+127
| +1% | +$3.88K |
|
2375
Winmark
WINA
$1.26B
| $368K | ﹤0.01% |
961
+33
| +4% | +$12.3K |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.